Pharmaceutical composition and method for regenerating myofibers in the treatment of muscle injuries
    1.
    发明授权
    Pharmaceutical composition and method for regenerating myofibers in the treatment of muscle injuries 有权
    用于再生肌纤维治疗肌肉损伤的药物组合物和方法

    公开(公告)号:US09155744B2

    公开(公告)日:2015-10-13

    申请号:US11722915

    申请日:2006-10-27

    摘要: A pharmaceutical composition and method for regenerating cardiomyocytes in treating or repairing heart muscle damages or injuries caused by an ischemic disease. The pharmaceutical composition contains an active ingredient compound with a backbone structure of Formula (I). The active ingredient compound is capable of (a) increasing viability of myogenic precursor cells to enable said precursor cells to survive through an absolute ischemic period; (b) reconstituting a damaged blood supply network in said heart region where said injured muscle is located; and (c) enhancing cardiomyogenic differentiation efficiency of said precursor cells down cardiac linage, said steps being performed simultaneously or in any particular order.

    摘要翻译: 用于再生心肌细胞治疗或修复由缺血性疾病引起的心肌损伤或损伤的药物组合物和方法。 药物组合物含有具有式(I)的骨架结构的活性成分化合物。 活性成分化合物能够(a)增加肌原性前体细胞的活力,使所述前体细胞能够通过绝对缺血期生存; (b)在所述受伤的肌肉位于的所述心脏区域中重建损伤的血液供应网络; 和(c)提高所述前体细胞向下心肌的心肌分化效率,所述步骤同时进行或以任何特定的顺序进行。

    Pharmaceutical Composition and Method for Neoangiogenesis/Revascularization Useful in Treating Ischemic Heart Disease
    2.
    发明申请
    Pharmaceutical Composition and Method for Neoangiogenesis/Revascularization Useful in Treating Ischemic Heart Disease 审中-公开
    用于治疗缺血性心脏病的新血管生成/血运重建的药物组合物和方法

    公开(公告)号:US20120252744A1

    公开(公告)日:2012-10-04

    申请号:US13517600

    申请日:2012-06-14

    IPC分类号: A61K31/7034 A61P9/10

    摘要: A pharmaceutical composition and a method of treating ischemic heart diseases by growing new blood vessels that supply oxygen and nutrients to infarcted heart tissues throughout the entire infarct zone and for preventing cardiomyocyte apoptosis in ischemic events. The pharmaceutical composition contains an active ingredient compound with a backbone structure of formula (I).

    摘要翻译: 一种药物组合物和通过生长新的血管来治疗缺血性心脏病的方法,所述新血管向整个梗塞区域的梗死心脏组织供氧和营养,并用于预防缺血事件中的心肌细胞凋亡。 药物组合物含有具有式(I)的骨架结构的活性成分化合物。